Pharming Group N.V. logo

Pharming Group N.V.

PHAR • NASDAQ

Pharming Group N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Fabrice Chouraqui, with a market cap of $1.2B.

Market Cap$1.2B
Employees382.0
CEOFabrice Chouraqui
CountryNetherlands
Healthcare
Biotechnology
Next EarningsMay 7, 2026 · In 1 weekBefore Market Open · Q1 2026
Income StatementBalance SheetCash FlowBusiness Segments

Financials

View all metrics

Revenue

View metric

Net Income

View metric

Operating Cash Flow

View metric

EPS (Diluted)

View metric
Pharming Group N.V. logo

Pharming Group N.V. FAQ

Common questions about Pharming Group N.V.

Pharming Group N.V. is scheduled to report earnings for Q1 2026 on May 7, 2026 before market open. Analysts estimate revenue of $92.1M.

Pharming Group N.V. has approximately 382 employees.

Cookie Preferences

We use cookies for analytics. See our Privacy and Cookie Policy.